On April 30, 2026, Nicole Saphier has been nominated by President Donald Trump as the next U.S. surgeon general. This decision follows the controversial withdrawal of Casey Means, who faced significant pushback due to her medical qualifications and views on vaccines.
Before this nomination, there was a growing expectation that Means would take the position. However, her lack of a current medical license raised concerns among lawmakers and health professionals alike. The Biden administration had previously appointed a surgeon general with a strong public health background, setting a high bar for any successor.
Saphier’s nomination marks a notable shift in direction. She is a breast radiologist with extensive experience; she serves as the director of breast imaging at Memorial Sloan Kettering Cancer Center-Monmouth and is an associate professor at Weill Cornell Medical College. Trump praised her as a “STAR physician” who guides women through breast cancer diagnoses and treatment.
However, Saphier’s views on vaccines have stirred controversy. She has openly questioned the necessity of the hepatitis B vaccine for newborns and criticized COVID vaccine booster requirements as not always being evidence-based. These stances have raised concerns about her alignment with current health policy priorities.
Key facts about Nicole Saphier:
- Saphier is Trump’s third nominee for U.S. surgeon general during his second term.
- She authored “Make America Healthy Again” in 2020, focusing on health policy reforms.
- Her fellowship training was completed at the Mayo Clinic.
Experts are divided on the implications of Saphier’s nomination. Some view her as an effective communicator who can simplify complex health issues for ordinary Americans. Others worry that her vaccine skepticism may undermine public trust in vaccination efforts.
As discussions continue around her qualifications and views, it remains crucial to consider how this nomination will influence public health initiatives across the country. With Saphier at the helm, many hope for a renewed focus on early detection and prevention in cancer care.
